Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis

Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosisEvaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis, Published online: 24 May 2018; doi:10.1038/s41408-018-0086-3Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis

Source: Blood Cancer Journal - May 24, 2018 Category: Hematology Authors: Efstathios Kastritis Ioannis V. Kostopoulos Evangelos Terpos Bruno Paiva Despina Fotiou Maria Gavriatopoulou Nikolaos Kanellias Dimitrios C. Ziogas Maria Roussou Magdalini Migkou Evangelos Eleutherakis-Papaiakovou Ioannis P. Trougakos Ourania Tsitsilonis Source Type: research